Medicine and Dentistry
Cohort Analysis
100%
Diabetes Mellitus
100%
Patient with Diabetes
100%
Psoriasis
100%
Cotransporter
100%
Hazard Ratio
40%
Maturity Onset Diabetes of the Young
30%
Patient with Type 2 Diabetes
30%
Nephropathy
20%
Diabetes
10%
Liver Cirrhosis
10%
Antiinflammatory Activity
10%
Chronic Liver Disease
10%
Pyrin Domain
10%
Nucleotide Binding Oligomerization Domain Like Receptor
10%
Receptor Family
10%
Interleukin 17
10%
Comorbidity
10%
Inflammasome
10%
Keyphrases
National Cohort Study
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Psoriasis
100%
Patients with Diabetes Mellitus
100%
Hazard Ratio
40%
Inhibitor Treatment
40%
Type 2 Diabetes Mellitus (T2DM)
30%
Type 2 Diabetic Patients
30%
Renal Disease
20%
Insulin Dose
20%
Comorbidity
10%
Interleukin-17 (IL-17)
10%
Diabetes Duration
10%
Taiwan National Health Insurance Research Database
10%
Protective Effect
10%
Anti-inflammatory Effect
10%
Chronic Liver Disease
10%
NOD-like Receptor Protein 3 (NLRP3)
10%
Potential Confounders
10%
Psoriasis Pathogenesis
10%
Chronic Liver Cirrhosis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Cohort Study
100%
Psoriasis
100%
Cotransporter
100%
Non Insulin Dependent Diabetes Mellitus
30%
Kidney Disease
20%
Liver Cirrhosis
10%
Interleukin 17
10%
Antiinflammatory Activity
10%
Chronic Liver Disease
10%
Inflammasome
10%
Pyrin
10%
Nucleotide Binding Oligomerization Domain Like Receptor
10%
Comorbidity
10%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Cotransporter
100%
Antiinflammatory Activity
10%
NOD-like Receptor
10%
Pyrin Domain
10%
Interleukin 17
10%
Comorbidity
10%
Inflammasome
10%